313 related articles for article (PubMed ID: 26421979)
1. Growth hormone signaling pathways.
Carter-Su C; Schwartz J; Argetsinger LS
Growth Horm IGF Res; 2016 Jun; 28():11-5. PubMed ID: 26421979
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2.
VanderKuur J; Allevato G; Billestrup N; Norstedt G; Carter-Su C
J Biol Chem; 1995 Mar; 270(13):7587-93. PubMed ID: 7535773
[TBL] [Abstract][Full Text] [Related]
3. 2022 Cannon lecture: an ode to signal transduction: how the growth hormone pathway revealed insight into height, malignancy, and obesity.
Carter-Su C; Argetsinger LS; Svezhova N
Am J Physiol Endocrinol Metab; 2023 Nov; 325(5):E425-E437. PubMed ID: 37672248
[TBL] [Abstract][Full Text] [Related]
4. SH2-B and SIRP: JAK2 binding proteins that modulate the actions of growth hormone.
Carter-Su C; Rui L; Stofega MR
Recent Prog Horm Res; 2000; 55():293-311. PubMed ID: 11036942
[TBL] [Abstract][Full Text] [Related]
5. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of the adaptor protein SH2B1β regulates its ability to enhance growth hormone-dependent macrophage motility.
Su HW; Lanning NJ; Morris DL; Argetsinger LS; Lumeng CN; Carter-Su C
J Cell Sci; 2013 Apr; 126(Pt 8):1733-43. PubMed ID: 23444381
[TBL] [Abstract][Full Text] [Related]
7. Role of the tyrosine kinase JAK2 in signal transduction by growth hormone.
Carter-Su C; Rui L; Herrington J
Pediatr Nephrol; 2000 Jul; 14(7):550-7. PubMed ID: 10912517
[TBL] [Abstract][Full Text] [Related]
8. In vivo targeting of the growth hormone receptor (GHR) Box1 sequence demonstrates that the GHR does not signal exclusively through JAK2.
Barclay JL; Kerr LM; Arthur L; Rowland JE; Nelson CN; Ishikawa M; d'Aniello EM; White M; Noakes PG; Waters MJ
Mol Endocrinol; 2010 Jan; 24(1):204-17. PubMed ID: 19884384
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton.
Rico-Bautista E; Negrín-Martínez C; Novoa-Mogollón J; Fernández-Perez L; Flores-Morales A
Exp Cell Res; 2004 Mar; 294(1):269-80. PubMed ID: 14980520
[TBL] [Abstract][Full Text] [Related]
10. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
[TBL] [Abstract][Full Text] [Related]
11. Signaling molecules involved in coupling growth hormone receptor to mitogen-activated protein kinase activation.
Vanderkuur JA; Butch ER; Waters SB; Pessin JE; Guan KL; Carter-Su C
Endocrinology; 1997 Oct; 138(10):4301-7. PubMed ID: 9322943
[TBL] [Abstract][Full Text] [Related]
12. Domains of the growth hormone receptor required for association and activation of JAK2 tyrosine kinase.
VanderKuur JA; Wang X; Zhang L; Campbell GS; Allevato G; Billestrup N; Norstedt G; Carter-Su C
J Biol Chem; 1994 Aug; 269(34):21709-17. PubMed ID: 8063815
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone-dependent phosphorylation of tyrosine 333 and/or 338 of the growth hormone receptor.
VanderKuur JA; Wang X; Zhang L; Allevato G; Billestrup N; Carter-Su C
J Biol Chem; 1995 Sep; 270(37):21738-44. PubMed ID: 7545168
[TBL] [Abstract][Full Text] [Related]
15. Growth-hormone signal transduction.
Campbell GS
J Pediatr; 1997 Jul; 131(1 Pt 2):S42-4. PubMed ID: 9255227
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor and lysophosphatidic acid inhibit growth hormone binding and signaling via a protein kinase C-dependent pathway.
Rui L; Archer SF; Argetsinger LS; Carter-Su C
J Biol Chem; 2000 Jan; 275(4):2885-92. PubMed ID: 10644756
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1.
Argetsinger LS; Hsu GW; Myers MG; Billestrup N; White MF; Carter-Su C
J Biol Chem; 1995 Jun; 270(24):14685-92. PubMed ID: 7782332
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues.
Thirone AC; Carvalho CR; Saad MJ
Endocrinology; 1999 Jan; 140(1):55-62. PubMed ID: 9886807
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
20. A role for Grb2-associated binder-1 in growth hormone signaling.
Kim SO; Loesch K; Wang X; Jiang J; Mei L; Cunnick JM; Wu J; Frank SJ
Endocrinology; 2002 Dec; 143(12):4856-67. PubMed ID: 12446613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
